Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database

The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly in most parts of the world, which is likely to increase the incidence of complications associated with the disease [1]. This situation calls for improved treatment of hyperglycaemia and other risk factors associated with T2DM in order to lower the risk of both micro- and macrovascular complications and their related economic costs, as proposed by all international and national consensus documents and guidelines [2 –6].
Source: Primary Care Diabetes - Category: Primary Care Authors: Tags: Original research Source Type: research